Novozymes offers new enzyme solutions to increase ethanol yields

At this year’s International Fuel Ethanol Workshop (FEW), Novozymes will unveil two new enzyme technologies designed to increase ethanol and corn oil yields and improve profits

bioethanol-pump

Two new fermentation solutions will join Avantec®, the Novozymes's advanced yield-enhancing liquefaction solution. According to a series of industry-scale trials, deploying all three technologies could mean significant additional profits for ethanol plants.

Launched just eight months ago, Avantec continues to deliver an average ethanol increase of 2.5% and energy savings of 2%.

Jack Rogers, Bioenergy Marketing Manager for Novozymes explains, "We saw up close and personal how last year's corn quality and prices negatively impacted our customers. We've seen how even small improvements in ethanol yield can have a huge impact on profitability. Avantec delivered the extra yield and energy savings some plants needed to make ends meet."

"Avantec was also the first step in a series of R&D insights that target all elements of the corn kernel," Rogers continues. "All three of our new yield-discovery solutions rely on uniquely advanced enzymatic activities that no other chemical or mechanical solution can provide. We believe that the combined ethanol yield increase they can deliver represents a new phase for the ethanol industry."

Novozymes officially unveils their new yield-discovery solutions on June 10th at the International Fuel Ethanol Workshop 2013 in St. Louis, MO, Booth 323.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

Philip Morris International Announces €300 Million Investment in Smoke-Free

Wednesday, 22 Mar 2017   |   Philip Morris International

Business Wire India Converting existing cigarette factory in Greece into a production facility for

Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® and Connectivity

Tuesday, 21 Mar 2017   |   Masimo

Business Wire India Masimo (NASDAQ: MASI) announced the CE marking of noninvasive blood pressure (NIBP)

Boehringer Ingelheim Phase III study now enrolling patients with progressive

Monday, 20 Mar 2017   |   Boehringer Ingelheim

Business Wire India For the first time, patients with different fibrosing lung diseases will be included

BusinessWire India.com - Pharmaceutical

Bwi-logo

Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® and Connectivity

Tuesday, 21 Mar 2017   |   Masimo

Business Wire India Masimo (NASDAQ: MASI) announced the CE marking of noninvasive blood pressure (NIBP)

Boehringer Ingelheim Phase III study now enrolling patients with progressive

Monday, 20 Mar 2017   |   Boehringer Ingelheim

Business Wire India For the first time, patients with different fibrosing lung diseases will be included

Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial

Monday, 20 Mar 2017   |   Boehringer Ingelheim

Business Wire India In the RE-CIRCUIT® trial, there were less major bleeding and fewer serious adverse

BusinessWire India.com - Medical Devices

Bwi-logo

Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® and Connectivity

Tuesday, 21 Mar 2017   |   Masimo

Business Wire India Masimo (NASDAQ: MASI) announced the CE marking of noninvasive blood pressure (NIBP)

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X